Biocon Ltd. | BIOCON | NSE - Pharmaceuticals
Financial Summary Report of Biocon Ltd.
BIOCON
Biocon Ltd.
Rs. 264.15
28-Mar-2024
5 Yr Performance
1 Yr Performance
Valuation
Analysis
Quarterly Revenue, Net Income and Adjusted Share Price
Peer Comparison
Glaxosmithkline Pharmaceuticals Ltd.